Skip to main content
4BASEBIO PLC logo

4BASEBIO PLC — Investor Relations & Filings

Ticker · 4BB ISIN · GB00BMCLYF79 LEI · 213800E2DX9EAIUNCB30 IL Manufacturing
Open in API
Filings indexed 92 across all filing types
Latest filing 2026-03-31 Regulatory Filings
Country GB United Kingdom
Listing IL 4BB

About 4BASEBIO PLC

https://www.4basebio.com/

4BASEBIO PLC is a biotechnology company specializing in the design and manufacturing of synthetic DNA for next-generation therapeutics and vaccines. The company provides high-purity, Good Manufacturing Practice (GMP) grade nucleic acid products, including its proprietary opDNA®, as a plasmid-free alternative to traditional methods. Its technology is engineered to accelerate development timelines, enhance safety, and improve manufacturing scalability for applications in genetic medicine, including mRNA vaccines, viral vector-based gene therapies, and gene editing. 4basebio's solutions aim to eliminate production bottlenecks and de-risk manufacturing for partners in the pharmaceutical and biotechnology sectors.

Recent filings

Filing Released Lang Actions
4basebio Plc - Lease of Manufacturing Facility
Regulatory Filings Classification · 0% confidence The document is a corporate announcement filed via the UK National Storage Mechanism. It describes an operational expansion (leasing a new facility) with no financial results, voting, share issuance, or other specific regulatory event. It does not match any other precise filing type, so it falls under the general regulatory announcements category.
2026-03-31 English
4basebio Plc - Appointment of COO
Board/Management Information Classification · 1% confidence The document is a formal announcement regarding the appointment of a new Chief Operating Officer (Scott Lorimer) at 4basebio PLC. It details his professional background, his role in the company's growth strategy, and includes quotes from the CEO and the new appointee. This fits the definition of a management change announcement.
2026-03-12 English
4basebio Plc - Appointment of CCO
Board/Management Information Classification · 1% confidence The document is an official announcement from 4basebio PLC regarding the promotion of Christine Wolosin to Chief Commercial Officer and other leadership changes within the commercial team. This falls directly under the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management.
2026-03-03 English
4basebio Plc - Leadership Changes
Board/Management Information Classification · 1% confidence The document is an official announcement from 4basebio PLC regarding the appointment of a new Chief Executive Officer and the resignation of the current CEO and CFO. This falls directly under the category of changes in senior management and board composition.
2026-02-10 English
4basebio Plc - Synthetic opDNA® utilised in Phase I/II US clinical trials
Regulatory Filings Classification · 1% confidence The document is a press release issued by 4basebio PLC announcing a clinical milestone regarding the use of their synthetic DNA in a partner's clinical trial. It is a corporate announcement of operational progress rather than a formal financial report, audit, or regulatory filing. As it does not fit into specific categories like M&A, dividends, or director dealings, and serves as a general corporate update, it is classified as a Regulatory Filing (RNS).
2025-10-27 English
4basebio Plc - Result of Extraordinary General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Result of Extraordinary General Meeting' and explicitly states that all resolutions proposed at the meeting were duly passed. This aligns perfectly with the definition of a Declaration of Voting Results, which covers official results from shareholder votes at any general meeting.
2025-10-10 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.